PCSK9 and cardiovascular disorder: PCSK9 binding to low-density lipoprotein receptor (LDL-R) disrupts the recirculation of LDL-R, thereby impairing the liver’s capacity to clear LDL-C from the bloodstream, resulting in elevated levels of LDL-C and the increased susceptibility to cardiovascular disease [8].